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ABSTRACT
An extensive literature has documented racial, ethnic, and socioeconomic disparities in
health care and health outcomes. We argue that the influence of geography in medical practice needs
to be taken seriously for both the statistical measurement of racial disparities, and in designing
reforms to reduce disparities. Past research has called attention to disparities that occur within
hospitals or provider groups; for example black patients who are treated differently from whites
within a hospital. We focus on a different mechanism for disparities; African-Americans tend to live
in areas or seek care in regions where quality levels for all patients, black and white, are lower. Thus
ensuring equal access to health care at the local or hospital level may not by itself erase overall
health care disparities. However, reducing geographic disparities in both the quality of care, and the
quality of health care decisions by patients, could have a first-order impact on improving racial
disparities in health care and health outcomes.
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jonathan.skinner@dartmouth.edu  During the past several decades, many studies have documented racial, ethnic, 
gender, and socioeconomic disparities in both medical care treatments and health 
outcomes.1  There are no easy economic explanations to explain such differences: 
African Americans seem less likely to receive invasive treatments even in the VA 
system, where doctors’ economic incentives are likely to be blunted (Peterson et al, 
1994; Whittle et al, 1993).  Nor do differences in insurance coverage seem to eliminate 
racial or gaps (Carlisle, 1997); indeed Ross and Mirowsky (2000) believe public 
insurance such as Medicare and Medicaid lead to worse health.   More recently, racial 
differences in cardiac surgery were hypothesized to depend on the race of the 
physician; however, no significant differences were found (Chen, et. al., 2001).   The 
Institute of Medicine’s (IOM) landmark study (Smedley et al, 2002) has conducted a 
comprehensive survey of the evidence and concluded that racial disparities in medical 
care treatments and outcomes are pervasive; this topic has also been an integral part 
of the National Research Council’s (NRC) research agenda (Martin and Soldo, 1997).  
 
Collectively these papers clearly document important racial differences in 
treatments, intensity of care, and outcomes.  In this paper, we consider a complicating 
factor that has implications for both statistical inference and policy recommendations 
regarding racial disparities: the geography of health care and health outcomes and its 
relationship to the measurement of racial health disparities.  This is a broad topic (see 
for example the work of Morenoff and Lynch (2002) in this volume), and so we will 
organize our contribution along five basic points:   
(1) There is considerable variation in the utilization of health care, and in outcomes, by region. 
  The phenomenon of “small area variation” in utilization rates has been studied 
for a number of decades.  Most recently the Dartmouth Atlas of Health Care has used 
nearly 100 percent samples of Medicare enrollees to measure such differences across 
306 Hospital Referral Regions (HRR) in the United States (Wennberg and Cooper, 
1999). Even after controlling for differences in underlying health status across regions, 
there is clear evidence of persistent and large differences in treatment patterns, even 
in contiguous areas.  Much of the current debate is how to interpret such differences, 
are they “demand” driven by patient preferences, or “supply” driven by physician 
beliefs and historical patterns of hospital location?  In addition to disparities in 
treatment patterns, there are also substantial variations in health outcomes by region.  
Recent research has documented race-specific and gender-specific variations at the 
                                                 
1  For a partial list of references, see Bluestein and Weitzman, 1995; Rathore et. al., 
2000; Chen, et. al., 2001; Alter, et. al., 1999; Peterson, et. al., 1997, Whittle, 1993, 
Gornick et al, 1996; and references therein. 
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county or state level in overall mortality rates as well as disease-specific mortality 
rates (Casper et al, 2001, Barnett et al, 2001).2   
(2) People who are African-American, Hispanic, and belonging to other minority groups tend 
to seek care from different hospitals and from different physicians compared to non-Hispanic 
whites.  
It is not surprising that African-American and Hispanic patients tend to see 
different physicians and are admitted to different hospitals compared to non-Hispanic 
whites.  This is largely the consequence of where people live: there are many fewer 
African-Americans seeking care in eastern Tennessee hospitals than in Mississippi 
hospitals, and many more Hispanic patients seeking care in hospitals in Florida, 
Texas, and California, than in Maine and New Hampshire.  Furthermore, patients of 
color who live in the same neighborhood as whites may go to different hospitals or 
(more clearly) see different physicians and in different settings owing to a variety of 
reasons including financial barriers, as well as racial barriers to care (Lillie-Blanton, 
Martinez, and Salganicoff, 2001).  Patients also tend to be seen by physicians of the 
same race, although one study (Harrison and Thurston, 2001) suggested this matching 
is in part the consequence of minority physicians being more likely to live near 
minority neighborhoods. 
(3) Racial disparities are pronounced in some areas, but are less so (or may not be present) in 
other areas.   
In most regions of the United States, there are pronounced racial differences in 
utilization and outcomes.  But in other areas, there are no significant racial differences. 
In some sense, this is welcome news, in that the medical profession is not some 
monolithic and uniform “system” that treats patients identically regardless of where 
they live.  Such differences, however, are not easily explained, and may rely on one or 
two surgeons who account for the majority of procedures in their region.  In other 
cases, the differences in racial disparities may arise from spatial “mismatches” of 
patients and physicians, for example because of segregation in residential areas, or the 
location of hospital facilities.3  
                                                 
2  Also see Skinner, Fisher, and Wennberg (2001) for measures of morbidity (i.e., heart 
attacks, stroke, gastrointestinal bleeding, colon cancer, lung cancer) across HRRs as 
developed in the Dartmouth Atlas of Health Care (Wennberg and Cooper, 1999). 
3  Gomes and McGuire (2001) have developed a very useful way to characterize non-
minority-minority gaps in utilization: racial differences in health care (i.e., the overall 
minority-non-minority gap regardless of cause), racial disparities (the difference after 
accounting for clinical appropriateness, need, and patient preferences), and racial 
discrimination (disparities after accounting for characteristics of the health care system 
and legal or regulatory climates).  Given how little is known about differences in 
preferences of patients, the comparisons presented below will not generally meet their 
criterion for disparities.    3
   
(4) These three facts create strong statistical interactions between geography and racial 
identity: one may falsely diagnose geographical variation as racial disparities, and conversely.   
On average, Hispanic Medicare enrollees account for the same level of 
expenditures as their non-Hispanic elderly counterparts (CMS, 2000, Table 4.8).  While 
this might reassure observers that there are no obvious utilization disparities between 
Hispanic and non-Hispanic Medicare enrollees, there is one complicating factor: 
geography.  Medicare expenditures on average are substantially higher in Florida, 
Texas, and California (Wennberg and Cooper, 1999).  Since a large fraction of Hispanic 
Medicare patients live in these three states, the researcher might well find that within 
each state, Hispanic patients experience lower utilization rates than their non-
Hispanic counterparts.   
More generally, in typical regression analysis when minority patients live in 
regions with systematically different rates of utilization (e.g., African-Americans in 
the south), and the region of residence is not controlled for, one can estimate larger or 
smaller racial “disparities” that are in fact the consequence of where people live, and 
not how they are treated or their outcomes within their community.  Nor are typical 
regional measures, such as MSA, necessarily accurate mirrors of “local” effects.   
It is important to note here that we do not argue against the existence of racial 
disparities, nor do we argue that they are necessarily mitigated by geographical 
variation.  If African-Americans live in regions with poor hospital quality, then that in 
itself represents a valid source of racial disparities.  Instead, our central thesis is that 
ignoring geography (or mis-specifying it) will cause the analyst to “cry wolf” when 
true differences are nonexistent, or to falsely conclude that there are no differences 
when in fact there are substantial differences in the outcomes of interest.  
Furthermore, as we argue next, the policy prescriptions may well differ depending on 
whether the racial disparities are caused by regional variations instead of by 
differences in treatment within hospitals or communities.  
 (5) A potentially large part of overall health disparities in the United States may be the 
consequence of regional differences in treatment and outcomes.  Reducing geographic 
disparities in quality of care will benefit all Americans, but are likely to yield greater benefits 
to minority patients. 
  The policy implications of racial disparities are different depending on their 
proximate causes.   Racial differences arising within a hospital or even within a 
physician’s practice may reasonably be ascribed to differences in underlying health 
status, patient preferences, financial barriers, provider biases, or some combination of 
these four factors.  Here, however, the insights of the regional variation literature is 
relevant; it is not the case that the rate of therapeutic interventions for whites should 
be necessarily viewed as the “correct” or “desired” rate (Wennberg, 1986; Tu et al, 
1997).  This is because the white rate might reflect inappropriate care -- whites get too 
much done to them as in Schroeder et al, (2001) or too little care -- or because 
preferences for care may differ by race or gender.   4
   
When aggregate racial differences in outcomes are the consequence of minority 
patients being more likely to live in regions where everyone in the region experiences 
poorer outcomes, then the policy focus should be on disparities in geography – that 
specific regions be targeted to improve quality of care or reduce “flat of the curve” 
health care spending.4  Such policies would ensure that disadvantaged racial groups 
would be the major beneficiaries of quality improvements.   
 
I.  The Geography of Health Care 
  The measurement of regional variation in health care utilization is difficult for a 
variety of reasons.  First, a great deal of statistical power is necessary to measure 
utilization at the local level; even a sample of 50,000 observations quickly loses power 
when the data are partitioned into separate regions, and used to focus on specific 
diseases.  Small sample sizes and inadequate statistical power can generate spurious 
“area variation” just because of random noise in measured average rates.5  Second, the 
problem of migration to hospitals must be considered; Boston hospitals accept 
referrals from all over New England, and if these patients were counted, it might 
appear falsely that Boston residents are at elevated risk of hospitalization.  Third, one 
needs a sample that is not subject to selectivity bias.  For example, the sample of 
Medicaid patients, or of managed care patients, is not likely to be representative of the 
general population; Medicaid patients can become eligible because of serious illness, 
and managed care patients tend to be healthier than the general population.  Finally, 
the regions should correspond to actual migration patterns of patients rather than 
artifacts of historical compromises such as state or county boundaries.   
In this section, we use data from the Dartmouth Atlas of Health Care that goes far 
to avoid these four shortfalls (Wennberg and Cooper, 1999; 1996).  The data comprises 
a nearly 100% sample of Medicare enrollees over age 65, often for two years, so the 
sample sizes are as much as 60 million person-years in a given map or graph; this 
provides considerable power for regional analysis.  Second, the Atlas defines one’s 
location by the zip code of residence, rather than where one actually gets care.  So if a 
patient from the Burlington VT region is admitted to a Boston hospital, that hospital 
stay (and any procedures done there) is assigned to Burlington, not Boston.   
Third, the Medicare data provide nearly 100 percent coverage of the population 
over age 65 and is the nearest thing to a national database of utilization in the U.S.  
                                                 
4  The ‘flat of the curve’ refers to a region where the marginal health intervention has zero impact 
on outcomes. For economists, this corresponds to the region of zero marginal product and this 
notion is formalized in Fisher et al, 1999; Skinner, Fisher, and Wennberg, 2001; Wennberg, 
Fisher, and Skinner, 2002.      
5  It is possible that much of the observed variation reflects random deviations from identical 
practice patterns across communities (Diehr, et. al., 1992).  While this possibility must be 
considered for smaller samples, the very large samples in the Medicare claims data preclude this 
explanation; also see McPherson et al. (1981). 5
   
There have been increases in the population of risk-bearing HMOs in the Medicare 
population (now referred to as Medicare+Choice), but that ratio never exceeded 12 
percent and has fallen as many insurance carriers have dropped Medicare+Choice 
option.  In some urban regions the ratio of HMO patients in the Medicare population 
has been higher than the national average, and this has engendered more concern 
about selection bias.6  
The Dartmouth Atlas has divided the U.S. into 306 Hospital Referral Regions 
(HRR), the unit of analysis at which health care for the elderly is delivered and are 
computed by using complex algorithm of commuting patters and the location of 
major referral hospitals.7  HRRs are named for the hospital service area containing the 
referral hospital or hospitals most often used by residents of the region. The regions 
sometimes cross state boundaries-- an attribute that is eo nomine ruled out by cross-
state analysis. Intuitively, one may think of HRRs as representing the geographic level 
at which “tertiary” services such as cardiac surgery are received.  
  To demonstrate the construction of the HRRs, in Figure 1 we detail the 
construction of the Evansville, Indiana HRR. This region comprises three states: 
Illinois, Indiana, and Kentucky. In this region, three hospitals provide cardiovascular 
surgery services. Two were in Evansville; a third hospital, in Vincennes, Indiana. The 
Evansville HRR also demonstrates that the inclusion of simple MSA fixed effects does 
not account for geography adequately: the US Census’ Evansville-Henderson MSA is 
actually comprised of three HRRs. This is not a problem in itself. However, if different 
HRRs have different practice styles, then it blurs the measure of true regional 
differences in utilization by aggregating up to the state or MSA level. To demonstrate 
the overwhelming degree to which even adjacent HRRs practice different “styles” of 
medicine we now draw on the findings of the Dartmouth Atlas of Health Care. 
  Figure 2 demonstrates that Medicare payments for services reimbursed on a 
fee-for-service basis (including non-risk bearing health maintenance organizations) 
were $4,993 for each beneficiary. However, even after controlling for age, sex, race, 
illness patterns, and differences in regional prices, reimbursements per enrollee varied 
greatly: as noted in the Atlas, these ranged from $9,033 in the McAllen, Texas hospital 
referral region to $3,074 in Lynchburg, Virginia.8    
                                                 
6  In statistical analysis, controlling implicitly for selection using the percent HMO enrollees in 
the area has not affected empirical estimates.  Beginning in 2000, HMOs were expected to report 
hospital procedures to CMS (Centers for Medicare and Medicaid Services), suggesting better 
data on managed care enrollees in the future. 
7  For further details on the construction methods see 
http://www.dartmouthatlas.org/99US/toc8.php. 
8  Illness has been controlled for by using age-sex-race specific mortality and hospitalizations 
rates for five conditions: hip fracture, cancer of the colon or lung treated surgically, gastro-
intestinal hemorrhage, acute myocardial infarction or stroke. These conditions were chosen 
because hospitalization for them is a proxy for the incidence of disease. The cost of living indices 6
   
  In Figure 3 the Atlas illustrates the enormous geographic variation in a 
relatively standard procedure— angioplasty (PTCA), an invasive procedure in which 
a catheter is inserted in the thigh and guided to the narrowed artery, where a balloon 
is expanded to clear the blockage and improve blood flow.  PTCA is often used 
immediately following a heart attack, or shortly thereafter, or to relieve pain for 
patients with ischemic heart disease.   In 1996 over 200,000 of these procedures were 
conducted with an average rate of 7.5 per 1000 Medicare enrollees. As in previous 
figures the data have been standardized for demographics are reported at the HRR 
level. Note how in Texas, Pennsylvania and California the ratio of rates (to the US 
average) can vary drastically even across adjacent HRRs.   
  The same pattern exists for other surgical procedures. Figure 4 summarizes the 
variation in rates (on a log scale) at which 10 common surgical procedures are used 
relative to the US average (in 1996). Similar results have been documented for the 
variation in rates at which different diagnostic tests are utilized. Together the 10 
procedures listed in Figure 4 comprised 42% of Medicare inpatient surgery and 
accounted for 44% of reimbursements for surgical care in 1995-96. For many of these 
procedures, regional variation occurs because of fundamental uncertainty about the 
effectiveness of the procedure and ambiguity about the efficacy of alternatives. For 
example, variation in rates of radical prostatectomy might be partly attributable to the 
lack of controlled clinical trials comparing the risks and benefits of surgery, radiation 
therapy, and watchful waiting. For other procedures, even the best clinical trials are 
often not sufficient to eliminate variation in procedure rates: physicians vary in how 
they interpret and apply findings from the carefully controlled settings of clinical 
trials to decision making for individual patients in other settings. The variation for 
hip-fractures is small because the fracture can be easily diagnosed and there is 
virtually all physicians agree on the appropriate treatment therapy. The observed 
variation therefore more accurately reflects variation in the actual rate of the hip-
fractures. Similarly, hospitalizations for colectomy reflect variations in the incidence of 
colorectal cancer, rather than differences in treatment strategies.  
One might suspect that these variations may be in part the consequence of 
differences in underlying patterns of cardiovascular disease.  Certainly one might 
expect that HRR-level rates of PTCA should be associated with HRR-level rates of 
heart attacks (Acute Myocardial Infarctions).   This is because nearly one-third of heart 
attack patients are treated with PTCA, and as well, community rates of AMI should be 
correlated with true (diagnosed and undiagnosed) levels of ischemic heart disease.  
However, the correlation coefficient (weighted by the Medicare population) between 
PTCA rates and AMI rates is essentially zero (correlation= .05, p = 0.35) and not 
significant, meaning that these variations are unlikely to be explained by differences 
in cardiovascular health status. 
                                                                                                                                                 
were computed by using non-medical regional price measures. Doing so avoids contaminating 
the analysis with physician workforce or hospital market conditions. 7
   
 The provocative nature of these results has not gone unnoticed and several 
hypotheses have been put forward to explain these variations. These include the role 
of sampling variation, differences in underlying severity, patient preferences, the role 
of capacity and the nature of physician learning. Wennberg, Fisher and Skinner (2002) 
demonstrate that higher Medicare spending does not result in more high-quality care 
such as flu vaccines, use of Beta blockers when appropriate, or better health outcomes. 
Instead, higher spending is typically associated with more “supply-sensitive services” 
such as physician visits, specialist consultations, and days in the Intensive Care Unit 
(ICU). Supply sensitive services are those that are provided in the absence of specific 
clinical guidelines on frequency of use, and where medical texts provide little 
guidance. Utilization rates for such services appear to be highly correlated with the 
supply of resources-- the number of physicians, specialists, labs and beds. As such, 
there appears to be little support for the notion that costs or inadequate training drive 
practice variation.  
Another class of rationalizations is developed in Phelps and Mooney (1993) and 
Bikhchandani, Chandra, Goldman and Welch (2002) who suggest that explanations 
based on the nature of physician learning are most likely to account for much of the 
empirically observed locality of treatment. In the Phelps-Mooney model, physicians 
are Bayesian learners, who attempt to reach an optimal rate for the application of a 
particular treatment. Eventually, as physicians sample both their own and their 
colleagues experiences, the two will converge towards an optimal rate. This 
hypothesis suggests a number of implications: a physician's propensity to treat 
converges toward the community norm, and faster if the community is more 
informed and the doctor is less informed (e.g., younger).  Among the implications of 
this theory is the hypothesis that the provision of more precise medical information in 
medical studies can enhance the learning of physicians, and thus offer dramatic social 
efficiency gains. Bikhchandani, Chandra, Goldman and Welch (2002) consider a 
modification of this model and demonstrate that it is possible for physicians to fall 
into a localized “cascade” because of the difficulty in experimenting with alternative 
treatment choices.   
The message of Figures 2, 3 and 4 is that the practice or “intensity” of medicine 
varies tremendously across space.  But there are also large differences within states 
and even within cities.   Fisher et al (1994) construct cohorts of Medicare beneficiaries 
on the basis of initial hospitalization for either AMI, stroke, GI bleeding, hip fracture, 
and surgery for breast, colon or lung cancer. They find that there are substantial 
differences in the intensity with which beneficiaries were treated (as measured by 
readmission rates) even across similar teaching hospitals in the Boston area. 
Specifically, there is substantial variation across the readmission rates for 
Massachusetts General Hospital, Brigham and Women’s Hospital, Beth Israel, and 
Boston University Medical Center. Most interestingly, there is no relationship between 
mortality (both 30 day and over the entire study period) and the intensity of 
hospitalization.   Clearly, racial differences in migration patterns to hospitals of 8
   
patients within Boston could have first-order effects on utilization rates although in 
this case, probably not with respect to outcomes. 
 
II.  Racial Differences in Where (and From Whom) Health Care is Provided 
  A variety of studies have documented the large differences in insurance status 
and presence of regular providers (versus emergency room visits) among African-
Americans, Hispanics, and non-Hispanic whites (e.g., Lillie-Blanton, Martinez, and 
Salganicoff, 2001).  As well, simple differences in where people live will lead to 
minority patients being seen at different hospitals, and by different providers, from 
whites.  This is not terribly surprising; clearly hospitals in Washington DC will be 
more likely utilized by African-Americans and Hispanics than those in Minot, South 
Dakota.   
To capture this difference, we use a nearly 100% sample of Medicare fee-for-
service patients who were admitted for a heart attack, or acute myocardial infarction 
(AMI), in 1998-99, these data come from the National Bureau of Economic Research 
Medicare claims panel developed by Mark McClellan and his colleagues.  There were 
a total of 468,663 admissions in the two years to 4,737 separate hospitals.  Nonblack 
admissions totaled 439,350, while black admissions were 29,313.  We use a Lorenz 
curve approach to characterize the extent to which black and nonblack AMI patients 
tend to be admitted to different hospitals, as shown in Figure 5. The 4737 hospitals 
were sorted according to the total number of black AMI Medicare patients admitted 
during 1998-99, starting with the lowest number (to the left) and ranging to the right 
of the graph with hospitals comprising the largest number of black patients.  The scale 
on the horizontal axis is the percentage of total nonblack patients in the sample.  The 
scale on the vertical axis is the percentage of black patients in the sample.  Given we 
have sorted hospitals in this way, we then plot the cumulative percentage of black 
admissions on the vertical axis, and the cumulative number of nonblack admissions 
on the horizontal axis. 
The 45 degree line in Figure 5 is the hypothetical line one would get if perfect 
equality held in the distribution of black and nonblack patients by hospital.  That is, if 
every hospital admitted 6.25 black patients per 100 nonblack patients (i.e., .0625 = 
29,313/468,663), then the hospitals accounting for 50 percent of nonblack patients 
would also account for the cumulative total of 50 percent of black patients.  (The 
analogy in the economics literature is that the 45 degree line in the Lorenz curve 
characterizes perfect equality of income.)   
As is clear from the graph, however, there is very little equality with regard to 
hospital admissions.  For slightly more than one-fifth of nonblack AMI patients, they 
are admitted to hospitals with no black AMI patients.  Point A shows that 50 percent 
of nonblack Medicare patients are admitted to hospitals that account for just 9 percent 
of black patients.  And point B shows the converse statistic, that 50 percent of black 
AMI patients are admitted to hospitals that combined account for just 14 percent of 9
   
nonblack AMI patients.  The Gini coefficient (or the ratio of the area between the 45 
degree line and the curved line, divided by the total area underneath the 45 degree 
line) is 0.61.  As such, the results of Figure 5 suggest that even thirty-five years after 
the passage of Title VI and VII of the Civil Rights Act which forbade de jure 
segregation and discrimination, considerable de facto selection by race still occurs in 
the hospitals that whites and blacks seek care. 
 These patterns are not unique to hospital admissions, and it is likely that 
differences in where whites and minorities seek care may ultimately reflect differences 
in where they live. The important work of Douglas Massey (2001) on residential 
segregation confirms our intuition on this fact. Using data on thirty major US cities, 
Massey finds dissimilarity indices (the relative number of minorities that would have to 
migrate in order to establish a uniform distribution of race across neighborhoods) 
range from 67 in southern cities to 78 in northern ones; 9 larger cities like Chicago, 
Cleveland, Detroit and New York had isolation indices of over 80 (implying that in 
these cities the average African American inhabits a neighborhood that is more than 
80 percent black).10   
A similar story to racial differences in the hospitals where minorities seek care 
holds for physicians.  In a recent study, Harrison and Thurston (2001) first 
demonstrated considerable “matching” between minority physicians and minority 
patients.  The degree to which racial matching occurs is striking-- in 1991, 47 percent 
of patients seen by black physicians were black (versus 17 percent for white non-
Hispanic physicians), and 30 percent of patients seen by Hispanic physicians were 
Hispanic (versus 9 percent for white non-Hispanic physicians).  However, the 
differences between white and minority physicians are substantially reduced when 
the analysis controls for location according to the zip code of the physician’s practice.  
As the authors suggest, improving health care services for minority population can be 
addressed both by increasing the number of physicians (of any race) who live in the 
area, as well as by increasing the numbers of minority physicians.   (See also Cooper-
Patrick et al. (1999), however, who find greater patient satisfaction and treatment 
adherence when there is concordance in racial identity between provider and patient.) 
  These results are useful reminders that when health care more generally 
exhibits such wide variations across areas, these area differences could well be 
reflected as racial differences at the aggregate level.  What is not as well known is how 
much of the actual differences in where one lives (i.e., the zip code of residence) and 
                                                 
9  Values of the index over 60 are considered high. It means that 60% of the members of one 
group would need to move to a different neighborhood in order for the two groups to be equally 
distributed. 
10  The isolation index measures the extent to which minority members are exposed only to each 
other, and is calculated as the minority-weighted average of the minority proportion in each 
area.  10
   
selective migration to different hospitals conditional on where one lives (i.e., whether 
blacks and whites in a given zip code go to different hospitals). 
  Furthermore, it is important to put these differences in health care providers in 
the context of the many other effects of neighborhood on health status more generally.  
Morenoff and Lynch (2002) have documented the multiple and dynamic causal 
pathways by which neighborhood-specific factors can influence long-term health 
outcomes independent of the type or nature of health care.  Thus access to health care, 
and quality of health care, are but two of a variety of factors affecting health that are 
likely to vary by neighborhood of residence.  The work of Oliver and Shapiro (1995) 
and more quantitatively, Smith and Kingston (1997) provides additional perspective 
on understanding these facts. Smith and Kingston emphasize noting the difference 
between income (a relatively transitory measure of SES) and wealth (a more 
permanent index of SES). Smith and Kingston document that wealth disparities across 
race are substantially larger than income disparities.   What is not well understood is 
the extent to which wealth as well as income can explain racial variations in health 
care utilization, and health care outcomes.    
 
III.  Geographic Variations in the Extent of Racial Differences: An Example  
Few studies of racial disparities treat such differences at a regional level.  In 
part, this is the consequence of power considerations; there are not enough 
observations in most data sets to distinguish racial differences in utilization across 
regions.  Mark McClellan and his collaborators have constructed a long panel of AMI 
patients, and in recent work Katherine Baicker conducted preliminary research on 
state-level differences in treatment patterns (Baicker, 2002).  Figure 6 provides uses 
these data to provide measures of angioplasty use for several selected states during 
1990-95 using a sample of fee-for-service Medicare patients admitted to hospital for 
AMI.11  As well, the U.S. national rates are presented based on a sample size of more 
than one million Medicare patients.  These estimates are adjusted for two broad age 
categories (age 65-80 or greater than 80), gender, and income (whether in the bottom 
quintile of zip codes as sorted by race-specific income).   Generally, sample sizes were 
very large, and the 95% confidence intervals for black PTCA rates were (at most) 
±0.025 in the smallest state, Massachusetts, and generally an order of magnitude 
smaller among nonblacks and in larger states (e.g., ±0.0063 for blacks in New York.)   
Figure 6 shows the remarkable heterogeneity in PTCA rates across selected 
states and across race in these states.  On average, there was a large gap in PTCA rates 
in the U.S., with rates for blacks just 69 percent of those for nonblacks; this result has 
been established in many other studies.  However, a state-by-state analysis suggests 
some variability in the magnitude of the disparities.  In Massachusetts, rates are 
slightly higher among black Medicare patients, although the results are by no means 
                                                 
11  States are used instead of HRRs to increase statistical power. 
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statistically significant.  By contrast, black PTCA rates in Arkansas are just 23 percent 
of the nonblack rates (p < .001).   Most states are closer to the national mean difference,  
such as New York (black rates 62 percent of nonblack rates) and California (69 percent 
of nonblack rates).  Note also the considerable degree of variation across states, so that 
the PTCA rates for black Medicare patients in California (13.9 percent) are higher than 
nonblack rates in New York (8.8 percent).   
These results are obviously quite preliminary and have not been fully risk-adjusted, 
so they should be interpreted cautiously.  Nonetheless, they suggest that racial 
disparities in utilization are not entirely uniform across regions. 
IV.  The Interaction Between Geography and Racial Disparities: Statistical Issues 
The standard approach to measuring racial disparities in health data makes 
careful efforts to control for a variety of risk adjusters that include health status, 
comorbidities, possibly clinical data on admission, demographic information, and 
where possible income.  Often, in quantitative studies, region is not included, either 
because region is suppressed because of concerns about confidentiality, or because of 
difficulty in how to interpret regional differences.   
To see how region can interact with measures of health disparities in a 
statistical sense, it is useful to begin with a simple example.   Table 1 shows 
cardiovascular deaths by race for men in two states, Massachusetts and Mississippi; 
these statistics were developed by a team of researchers and published by the CDC 
(2001).  (Results are similar but not as pronounced for women).  Were we to combine 
the data and consider the difference in age-adjusted mortality rates for cardiovascular 
disease for both states, we would find black mortality rates of 900 per 100,000, and for 
whites, a corresponding rate of 668.12  In other words, cardiovascular disease is 35 
percent higher for blacks than for whites. 
  However, note that rates of cardiovascular deaths in Mississippi are higher for 
both blacks and whites.  Within Mississippi, rates are 24 percent higher for men, and 
within Massachusetts, black cardiovascular rates are actually 6 percent below those 
for white men.  Indeed, the overall weighted elevated risk for cardiovascular disease 
is 15 percent once state-level differences are accounted for.  Furthermore, all of the 
additional mortality is occurring not in Massachusetts, but in Mississippi. 
There are many scenarios in which the 35 percent elevated rate would be 
relevant; for example, how much at risk are African-Americans overall to 
cardiovascular disease?  However, from a policy viewpoint it is useful to decompose 
that 35 percent difference into two parts: that part owing to within state differences 
(15 percent) and the remaining 20 percent that is caused by African Americans being 
more likely to live in a state where everyone experiences higher cardiovascular 
                                                 
12  Population weights are for the state-specific African-American and non-African 
American population for both men and women, and not just men alone (Statistical 
Abstract 2001, p. 28). 12
   
mortality rates.  The latter 20 percent (which comprises almost 60% of the total 35 
percent disparity) is perhaps best addressed by improving health behaviors and 
health care for all citizens of Mississippi.   
The point of this exercise is not to argue that the 35 percent elevated rate 
observed in these two states is not the consequence of deep-rooted discrimination, nor 
does it rule out the presence of disparities in health among blacks even in 
Massachusetts.  Instead, we are trying to suggest that it is useful to decompose overall 
black-white differences in health outcomes (or health care utilization) into two parts. 
First, there could be discrimination by providers and hospitals (or the healthcare 
system) and second, there could be economic and social discrimination (or a historical 
legacy) that affects the location decisions of minorities.  Our paper focuses on the role 
of the first source of disparities and not on the second.  It is critical to note that ruling 
out the first, does not rule out the second (or for that matter, vice versa).  
A similar issue can be seen in evaluating quality of care for blacks and whites 
as measured by specific treatment regimes for acute myocardial infarction (AMI) 
patients.  For example, beta-blockers are effective in extending survival because they 
lower blood pressure and reduce the demands placed upon a weakened heart 
following AMI.   Most clinicians would agree that the rate of beta-blockers among 
patients when appropriate should be close to 100 percent.  Yet as one important study 
demonstrated using data from the Cooperative Cardiovascular Project during 1993-94, 
actual rates of compliance were considerably below 100 percent, and in some states 
were below 50 percent (Jencks, 2001).  Figure 7 graphs on the vertical axis the 
percentage of AMI patients for whom chart review indicated that beta blockers were 
appropriate, while on the horizontal axis is graphed the percentage of people living in 
that state who were African-American; the lowest rate of compliance was in 
Mississippi (47%).13  .)  There is a distinct and significant negative correlation between 
the percentage of the state that is African-American and quality of care as measured 
by the use of beta-Blockers.14  A state-level regression implies that black rates of beta-
blocker compliance are 32 percentage points lower than for nonblacks.   
  However, another study that used the same CCP data found little overall 
differences in the use of beta-blockers at discharge by race (Rathore, et. al., 2000).  
Unadjusted odds ratios were 0.90, but after adjusting for differences in clinical 
presentation, the odds ratio was just 0.96 which, while significant, implied just a 1 
percentage point lower rate in the use of beta blockers for African-Americans.   
                                                 
13   We exclude Washington DC from this analysis. However, including Washington DC 
weakens the correlation, because it is an outlier with a 63 percent African-American 
population and 93 percent beta-Blocker use.  However, many of the patients treated in 
Washington DC are residents of Maryland and Virginia.  
 
14  We are grateful to Melinda Pitts for pointing out this correlation to us.    13
   
  Why the difference?  One reason may be that the model also adjusts for 
differences in poverty rates, which do exert a significant influence on beta blocker use 
(odds ratio = 0.93).   More importantly, however, the regression controlled for Census 
region and for hospital volume, and while Census regions are crude measures of 
regional variation, they effectively limit differences in utilization of beta blockers to 
within-region comparisons.  In other words, it is not simply the large African-
American population in Mississippi that leads to such low compliance with the use of 
beta blockers where appropriate; it would appear that white AMI patients in 
Mississippi are not getting beta blockers either.15  Nonetheless, this example illustrates 
the risks of making inferences about individual behavior based on aggregated data. 
  This problem is generally referred to as “ecological fallacy” and is well known 
in both the public health literature and in the political science literature. (Susser, 
1994a,b; King, 1997).  In theory, one can “solve” the ecological fallacy problem with 
the use of micro-level data with both race and location identifiers, but in practice that 
is often difficult.  And often one must aggregate data at some level to identify 
community or region-specific effects that may themselves reflect a variety of 
unmeasured confounding variables.   
  The results shown in Figure 7 are replicated for the more general measures of 
health care quality in Jencks et al (2000) in Figure 8 and are taken from Fisher and 
Skinner (2001).16  They show a southward progression from the  Northeast (NH, VT, 
ranked numbers 1 and 2 in state-level quality) to the deep south (LA, MS ranked 49 
and 50, respectively; Washington DC drops to 34 in the ranking).  The first point is 
that conventional t-statistics in state-level regressions are overstated; these are not 
independent draws of 50 states.  
As well, this graph displays Medicare spending by state in 1996.  The estimated 
spending values are adjusted for the fact that some states have more elderly people in 
the population, or a sicker population. (The elderly in states like Louisiana and West 
Virginia are indeed sicker – and we allow for their greater health needs in calculating 
per-capita Medicare spending.)  The spending data, from the Dartmouth Atlas of 
Health Care Working Group (www.dartmouthatlas.org) do show remarkable 
differences in per-capita Medicare spending across states, ranging from $2763 in 
Oregon to $5668 in Texas and $6307 in Alaska.  The pattern of the dots, each of which 
represents a state, shows that more spending per capita does not appear related to 
better quality -- if anything, it appears to be associated with worse care (Fisher and 
Skinner, 2001).   We do not believe that increasing spending will reduce the quality of 
                                                 
15  Mean beta blocker use differs between the two studies; 56 percent versus 72 percent, 
suggesting different criterion may have been used to determine appropriateness.  
16  Jencks (2000) ranks states on the basis of whether interventions that are known to be 
correct were administered for conditions such as AMI, heart failure, stroke, pneumonia, 
screening for breast cancer for women aged over 53 and eye-exams and lipid profiles for 
diabetics. 14
   
care.  Connecticut and Massachusetts are both high cost states, but ranked in the top 
ten in terms of quality.  Instead, we think that spending on Medicare is largely 
independent of how well physicians follow clinical guidelines for appropriate care 
such as giving the right set of drugs for heart attack patients, or screening for common 
and treatable diseases.   High quality care is not necessarily expensive care 
(Wennberg, Fisher, and Skinner, 2002). 
  The second point is that this pattern is replicated in other studies showing a 
correlation between outcomes and percentage African-American (Deaton and 
Lubotsky, 2001), rather than a correlation, as earlier hypothesized, between income 
inequality and mortality (Kennedy, Kawachi, and Prothrow-Stith, 1996).17 Because 
there are many factors that seem to align themselves along this geographical 
dimension from New England to the new South (percent black, income inequality, 
quality of health care, social capital), the ecological fallacy problem is particularly 
relevant here. The point to note from this figure is that the states where many blacks 
live-- Mississippi, Louisiana, Georgia and Alabama are all “low-quality” providers. 
The north-east tends to comprise the “high-quality” providers but as is well known 
these states have a small African American population.  
  Even when researchers do specify regional covariates, they are often not 
specific to actual geographical patterns of health care use and outcomes; while 
incorporating state or MSA fixed effects is an improvement over ignoring them, they 
are still a highly simplistic characterization of the data, since patient migration 
patterns are not necessarily constrained by state or MSA boundaries.  For example, 
blacks who live in Covington, Kentucky will find it much easier to seek care in 
Cincinnati, Ohio (1 mile away across the Ohio river) versus driving to Louisville, KY 
or Lexington, KY. The same story can be told for any large urban population center 
that encompasses several states (consider for example, large east coast cities such as 
Boston, Providence, Philadelphia, New York, Washington DC).18  And while the 
Dartmouth Atlas’ use of HRR attempts to circumvent these problems by using zip-
code location and migration data to assign individuals to hospitals, even these 
measures likely understate true differences across HRRs in utilization variability. 19   
                                                 
17 As such, percent African-American may be a better proxy for SES than income or other 
indirect measures of economic well-being. This interpretation is one that will be consistent 
with the results presented in our paper. It would however, not be a proxy for income or 
social-inequality as is conclusively demonstrated by Deaton and Lubotsky (2001). 
18  More technically, one might think of this error as being identical to measurement 
error in a covariate (geography, in our example). For a subset of observations, the wrong 
state has been included (Kentucky instead for Ohio). In general, measurement error 
biases the coefficient towards zero implying that the researcher is prone to incorrectly 
conclude that geography does not matter.  
19   For example, if 15% of the residents in HRR A seek care in the more aggressive HRR 
B, then because HRR measures of utilization are based on residence, the measured level 15
   
We next consider the statistical issues at a more general level: how specification 
of risk-adjusters and geography can dramatically affect the bias in estimated 
regression coefficients. To illustrate the importance of geography and focus the 
discussion we simplify the analysis and assume that high-quality data has been 
obtained that avoids problems with unmeasured confounding variables; any errors in 
measuring the “true” relationship arises because of model specification. For the 
purpose of these pictures geography may be thought to be a variable such as hospital 
quality; this link is especially persuasive if we recall the previous discussion on 
hospital quality and residential segregation.  
  Figures 9a-9c simulate the estimation of simple regressions, where the 
parameter of interest is the coefficient on race (in our simple example, the coefficient 
on an indicator variable for ‘Black’). In Figure 9a, we illustrate two data “clouds” for 
blacks and whites. Mortality is plotted on the y-axis and the x-axis measures the 
quality of healthcare provided at the relevant regional level. Ideally, this would be at 
the level of individual HRRs. blacks are shown to have higher mortality than whites. 
However, this is entirely shown to driven by geography-- blacks live in regions, or 
seek care at hospitals that provide low-quality care.  blacks and whites who live in the 
same region have the same outcomes.  As we showed above, omitting quality or the 
correct measure of geography from the regression and comparing the racial difference 
in mortality (risk-adjusted or otherwise) will yield an estimate of  
∆ = E[Mortality|Black]- E[Mortality|White].  
However, if whites are more likely to be seen at high quality hospitals than blacks, ∆ 
is overstated. In the true regression, there is no effect of race on mortality within 
hospitals or geographic area. 
  In Figure 9b we assume that within-area blacks receive worse care than whites, 
but that this differential is constant over areas. Here, African Americans have worse 
outcomes even within the same hospitals. This correct race difference is β2 (the 
distance between the lines for blacks and whites at the same level of quality, or within 
the same geographical unit). Omitting Quality or the correct measure of geography 
from the regression and comparing the racial difference in mortality (risk-adjusted or 
otherwise) will yield an estimate of ∆ = E[Mortality|Black]- E[Mortality|White]. It 
can be seen that ∆ considerably overstates β2. An indirect example of estimating this 
model may be seen in the careful work of Morrison et al (2000) who study the 
relationship between the racial composition of neighborhoods in New York and the 
degree to which pharmacies in these neighborhoods carried opioid supplies.20 After 
controlling for the fraction of the local population that is elderly at the census block 
                                                                                                                                                 
of utilization for HRR A would be higher than is the true level of utilization in its local 
hospitals. 
20 Opioids refer to codeine, morphine, and other drugs whose effects are mediated by 
specific receptors in the central and peripheral nervous systems. They are used for 
severe pain management in cancer patients.  16
   
level, the authors find that only 25 percent of the pharmacies in the largely non-white 
neighborhoods (those with non-white populations of 60 percent or larger) carried 
opioids. In contrast, in predominately white neighborhoods (those where over 80 
percent of the residents are white) over 72 percent of pharmacies carried the requisite 
supplies. The Morrison studies provides an intuitive description of the Figure 9a and 
10b: if the researcher does not control for geography and simply asks whether 
minorities are less likely to be near a well-stocked pharmacy (relative to whites), the 
conclusion would be yes. However, the point of Figure 9b is to note that whites who 
live in predominately non-white neighborhoods are also not near an adequately 
stocked pharmacy.  
 
In Figure 9c we illustrate the problems of ignoring differential quality effects. 
Here, African Americans have worse outcomes even within the same hospitals and 
the race difference grows in worse hospitals. This correct race differential is β1 Quality 
+ β2. Graphically, this is the height of the larger arrow. Omitting the Quality x Race 
interaction leads to severely understating the gap (the regression line will be weighted 
heavily by the white data), and the height of the smaller arrow is incorrectly estimated 
to be the race difference.   
In practice, of course, the problem of unmeasured confounding variables is 
quite serious, even for very good data sets such as the CCP.  Suppose the researcher 
estimates a model of the form: 
   M o r t a l i t y i = β0 + ZΓ + β1 Blacki + ui 
Mortality (say 30-day mortality after AMI) for the ith individual is regressed on a 
vector of risk-adjustment controls (the Z matrix), and an indicator variable for 
whether the individual was African American. Here, the coefficient on race (here, an 
indicator variable for whether the respondent is an African American) is the 
parameter of interest. If the risk-adjusters Z are complete then it is possible to 
interpret the estimated coefficient β1   as the effect of being black on mortality.  
However, the assumptions necessary to justify such a conclusion are very strong.  
First, as noted above, the presumption is that racial differences are the same across 
regions (as in Figure 9b), a finding that does not appear to be true in practice.  (One 
might still interpret the coefficient as a weighted average, of course.)   
Second, it presumes that the researcher has controlled for all biological or 
genetic differences that persist even once measurable risk-adjustment has been made. 
If controls for comorbidities are not complete and blacks are unobservably sicker than 
whites we will overstate the coefficient estimate for β1 ; otherwise the categorical 
variable on race will “pick up” all the unmeasured variables that differ by race.  For 
example, in evaluating the use of thrombolytics (medications that dissolve blot clots) 
for the treatment of coronary it is of first-order importance to know that such 
interventions are contraindicated for those patients who have had a recent 
hemorrhagic stroke.  If blacks are more likely to have suffered from a stroke, 17
   
documenting lower thrombolytic prescription rates alone, without appropriate 
covariates, is not meaningful.  
Third, the model as estimated presumes that the influence of either 
comorbidities or treatments are the same for both whites and blacks.  Barbara McNeil 
in her Shattuck Lecture, for example, emphasized the importance of noting clinically 
relevant drug and race interactions (McNeil, 2001).   For example, biological 
differences between races in receptor polymorphisms will cause different responses to 
the same drugs. A series of papers in the New England Journal of Medicine reflects these 
concerns. Among patients with congestive heart failure and left ventricular 
dysfunction, the use of enlaprin or bucindolol (ACE inhibitors) reduced 
hospitalizations for whites and nonwhites respectively but not for blacks (Exner et al, 
2001). Similarly, Chen et al. (2001) note African American patients who have had an 
AMI are more likely to have negative or oftentimes unclear cardiograms at the 
moment of presentation, thereby complicating the ensuing diagnoses.  
One approach to avoiding such statistical pitfalls is to use the insights of the 
Oaxaca-Blinder decomposition approach, used previously in the economics literature 
to evaluate racial wage disparities; (Oaxaca, 1973, 1975; Blinder, 1973) more recently 
this approach has been used to measure racial disparities in health care (Balsa and 
McGuire, 2001).  This approach counsels against pooling patient data across race or 
ethnic identity, but instead prescribes estimating the type of model above for just (say) 
whites.  One can then ask: what would be the implied results (whether utilization or 
health outcome) for blacks or Hispanics given their own levels of covariates Z and the 
set of coefficients estimated for whites, Γw.    
Skinner et al (2002) for example used this approach to measure differences in 
average hospital quality for African-American AMI patients.  They did not attempt to 
measure differences in outcomes between blacks and nonblacks within a given 
hospital directly. Instead, they used only nonblack AMI adjusted mortality rates to 
measure hospital “quality” for both blacks and nonblacks.  Thus if blacks tended to be 
admitted to hospitals with higher nonblack mortality rates, hospital quality was 
deemed to be lower for blacks than for nonblacks.  (The critical assumption in using 
nonblack mortality rates as a measure of quality is that the authors can adjust for 
differences in underlying health status for nonblacks living in largely black areas 
compared to nonblacks living in largely white areas.)  This focus on identifying the 
degree to which the observed racial disparities are explained by hospital quality alone 
has the strength of not being contaminated by other potentially important factors such 
as provider-patient interactions and patient preferences.  
In equation form, average 30-day mortality rates for whites at the national 
level, Mw, can be written as the weighted average of mortality rates for each of the i = 
1,…, N hospitals in the U.S.:  18
   
Mw = Σi fw(i)θ2w(i) 
where fw(i) is the transformed mean of Zw, and is equal to the fraction of nonblack 
Medicare AMI patients who are admitted to hospital i (so that Σi f(i) = 1) and Qw(i) is 
the quality measure, in terms of differential 30-day mortality, for hospital i among 
nonblack patients.   The alternative counterfactual measure of mortality Mw* is 
predicted mortality under the assumption that nonblack AMI Medicare patients are 
admitted to the same distribution of hospitals as are black AMI Medicare patients;  
Mw* = Σi fb(i)θ2w(i) 
where fb(i) is again the transformed value of Zb, the distribution of hospitals to 
which black AMI patients are admitted.  The difference, Mw – Mw*, is defined to be the 
component of mortality rates for black AMI patients that is the consequence of 
differential admission (by race) to high or low quality hospitals.   
  At first glance, this emphasis on geography and disparities may appear to 
contradict many of the findings reviewed in the recent IOM study (Smedley et. al., 
2002).  It seeks to explain the observed racial disparity that has been noted in the 
countless other studies (reviewed in the IOM report) as a function of differences in 
where care is sought.  It does not rule out the role of provider discrimination in 
explaining outcomes, but notes the striking degree to which whites and blacks who 
are seen at similar hospitals tend to have similar outcomes.  In fact, many of the 
studies reviewed in the IOM report are consistent with the findings of this paper. 
Consider for example, the IOM discussion of the 13 high-quality studies on racial and 
ethnic disparities in cardiovascular care. Out of the hundreds of studies that were 
reviewed by the Institute these 13 are highlighted because they use clinical (chart) 
data to adjust for co-morbidities, which is superior to the use of administrative data. 
Furthermore, they accounted for the use of cardiovascular services by including 
measures of the appropriateness of care. Of these studies only two, Leape et al (1999) 
and Carlisle et al (1999), found no racial and ethnic disparities in care after controlling 
for insurance status, co-morbidities, and severity.  
  What separates these studies from the others? We note that the Leape study 
uses data from thirteen New York hospitals and tests for racial differences in 
revascularization.    On the basis of the previously discussed RAND appropriateness 
criteria all patients in the study were classified as being proper candidates for the 
requisite intervention.   However it is important to also note that the analysis also 
controls for the hospital that the patient was seen as (through the inclusion of a 
hospital fixed effect).  As noted above, regions vary substantially with regard to the 
degree of racial differences in utilization; controlling for hospital effects could have 
further attenuated such differences.   
  These studies taken together suggest an additional focus for improving quality 
of care among the black elderly population.  If African Americans are more likely to 
be seen at low-quality hospitals, public-policies that attempt to improve hospital 19
   
quality would disproportionately benefit African-Americans. This conclusion remains 
consistent with one of the salient conclusions of the IOM report:  
Significantly, minorities access to better quality facilities is often limited by 
the geographic distribution of care facilities and patterns of residential 
segregation, which results in higher-quality facilities being less-accessible. 
(Preprint, chapter 3). 
 
 
V. Geography and Racial Disparities: Policy Implications and Conclusions 
Most of the literature on health disparities find dramatic differences in 
utilization by race, but are generally vague on the question of whether differences are 
driven by demand (for example, blacks do not want the more intensive care) or 
supply (physicians treat blacks with otherwise identical characteristics differently) or 
perhaps that blacks and whites differ by unmeasured health characteristics (e.g., 
Johnson et al, 1993) or respond to different nonmedical incentives such as insurance 
coverage.  Hence most studies do not provide strong policy prescriptions on how one 
goes about fixing the problem. It is often useful to characterize such differences into 
three general categories: 
  (1)  Preferences, or the underlying demand function for patients 
(2) “Supply” or physician, health professional, and hospital behavior 
  (3) Implicit and explicit “Prices,” or differences in insurance coverage, 
travel time, and other factors without explicit prices such as location of 
residence that are likely to affect behavior. 
A massive body of literature in social science and medicine may classified 
under the first two categories. Indeed, the recent IOM report provides a detailed 
literature review of these two categories. The report concludes that while a small 
number of studies demonstrate that minority patients are more likely to refuse care, 
these differences in refusal rates are insufficiently large to explain a significant share 
of the observed disparities. A smaller subset of studies has also considered the impact 
of insurance coverage and travel time on utilization.  We group location in this third 
categorization; in theory, an individual could travel 300 miles to a different hospital, 
but the costs of travel broadly defined (including the potential for adverse outcomes 
during the travel) are too high to make it feasible.  Most health care is local, and we 
believe that this third category is critical in evaluating both evidence for racial 
disparities, and developing policies to reduce such disparities. 
We would suggest that, if possible, racial disparities be decomposed into their 
proximate causes, for example with respect to “across hospital” variation (i.e., patients 
are more likely to be admitted to hospitals with perhaps less aggressive treatment 
protocol) and “within hospital” variation (i.e., black, Hispanic, and non-Hispanic 
white patients are treated differently within a hospital).  Both variations can lead to 20
   
lower utilization rates for minority populations, the difference however lies in the 
policy implications.  The latter type of variation clearly involves the internal workings 
of specific hospitals or provider groups, and further inquiry into causes of such 
differences (financial barriers, preferences of patients, or provider behavior) is clearly 
warranted.  The former type of variation, however, relates less to race per se and more 
to geographical variations in treatment patterns of all patients.  
It is particularly with these types of variations that the research on regional 
variations, health outcomes, and shared decision making provide illuminating 
lessons.  For example, a cursory examination of the medical and social-science 
literature on racial disparities in outcomes reveals that for almost every study, the 
white treatment rate is seen as the “gold-standard” to evaluate black outcomes 
against. This may or may not be the right approach: for economists interested in the 
study of the racial wage gap for example, it makes sense to view white wages or white 
test-scores as the standard against which black outcomes should be measured 
(Chandra, 2000, 2002). Increases in incomes, wealth or test-scores are viewed as being 
desirable, and decreases in these measures are unanimously viewed as being adverse 
events. However, with medical outcomes there are at least two reasons why the above 
logic may not translate over.  
  First, there are a number of recent studies that suggest “more is not necessarily 
better.” Simply put, the fact that whites have higher rates of PTCA or CABG following 
AMI does not necessarily mean that blacks ought to get the same rate (Schwartz et al, 
1999).21 This is because it is entirely possible that the white rate of PTCA is a 
consequence of aggressive medicine and is therefore not the desired benchmark. In 
the technical jargon of economics, if physicians are operation in a region of negative 
marginal product on the production function, then scaling back on intensity could 
actually improve outcomes.  Very similar issues are considered in asking whether 
some regions that practice more intensive health care are in fact practicing “flat of the 
curve” medicine with no observable benefit in terms of better health outcomes (Fisher 
et al, 1999, Skinner, et. al., 2001).   
  For example, in a widely publicized study, actors of difference races and 
gender described identical symptoms in videos that were then shown to physicians, 
who were then asked whether they would prescribe cardiac catheterization 
(Schulman et al, 1999;).22   The results of the study indicated that for the actors who 
were white males, black males, and white females, prescribed catheterization rates of 
                                                 
21  CABG-- Coronary Artery Bypass Grafting Surgery: Surgery in which a vein is 
harvested from the leg, or an artery is harvested from the internal mammary artery to 
bypass the coronary artery that has narrowed because of the buildup of atherosclerotic 
plaque.  
22 Cardiac catheterization (or an angiogram) is a nonsurgical procedure performed 
under X-ray guidance in the Cardiac Catheterization Lab to aid in the diagnoses of 
coronary artery disease.  21
   
about 91% were identical.  For the two actresses who were African-American, 
prescribed catheterization rates were 79%.  (These findings were reported to the 
media in a quite different way; see Schwartz et al, 1999.)  The researchers suggested 
such differences were evidence of provider discrimination, but what is not known is 
whether the 91% rate is too high or the 79% rate too low (or both) (Schwartz et al, 
1999).   This is a question that has been confronted as well in studies of geographical 
variation: we don’t know which rate is right (Wennberg, 1986; Tu et. al., 1997).   
  This point also constitutes the central thesis of a recent paper by Schneider, et al 
(2001).  In this important paper the authors use RAND criteria to classify CABG and 
PTCA procedures on a sample of Medicare beneficiaries who had all undergone 
coronary angiography. The sample was drawn from over 173 hospitals and each 
beneficiaries treatment was classified as being appropriate, uncertain and 
inappropriate.23 The authors found that there was substantial cross-state variation in 
the inappropriate use of both bypass surgery (CABG) and PTCA; for PTCA 
inappropriate rates were 24% in California, 14% in Pennsylvania, 8% in Georgia and 
12% in Alabama.  These regional differences clearly have implications for the 
percentage of Hispanics and African-Americans receiving inappropriate care.  
Furthermore, they find almost all of the measured racial gap in PTCA 
revascularization is explained by the higher rate of inappropriate care for whites as 
well as higher rate of PTCA that is viewed as being of “uncertain” legitimacy.  By 
contrast, they found lower rates of CABG use where appropriate among African-
American patients. 
   The null hypothesis in the racial disparities literature always appears to be that 
there should be no differences in utilization.  This is reasonable for procedures where 
nearly 100% of patients should be in favor of such treatments (immunization, eye 
exams for diabetics) or where 100% of patients should be against (inappropriate PTCA 
as above).  It is not unreasonable, however, that preferences for certain types of care 
may differ across patients, even for demonstrably effective elective surgical 
procedures (where appropriate) such as hip replacements.  It is highly unlikely that 
observed differences in utilization can be attributed solely to preferences, however.  
Preferences for a kidney transplant were slightly lower among African-American men 
and women, but these differences in preferences could explain only a fraction of 
overall racial differences in transplant rates (Ayanian, et. al., 1999).  When seriously ill 
patients were asked about preferences for life-sustaining technology, preferences 
among African-Americans were stronger for more intensive care (Hopp and Duffy, 
2000).  Still, it should be kept in mind that the null hypothesis is not exact equality 
                                                 
23  The RAND appropriateness criteria for CABG and PTCA are discussed in Leape, et al 
(1991) and Hilborne et al (1991). These criteria are not based on the cost of the procedure 
and classify a procedure as being appropriate or inappropriate based on the expected 
health benefit (quality of life or longevity) versus the expected health costs (probability 
of death, or disability). The criteria are constructed for almost 3,000 clinical scenarios or 
indications.  22
   
across racial or ethnic groups, but instead that rates of procedures (by race) match 
with informed preferences for that procedure. 
  To sum up, this paper has argued that local area variations need to be taken 
seriously in considering racial disparities in health care.  This is true for two reasons: 
statistical pitfalls can trip up otherwise careful and valid empirical research 
documenting the existence and prevalence of disparities.  And second, the policy 
solutions to racial disparities that occur because African-Americans and Hispanics 
tend to live in different places from non-Hispanic whites are quite different from the 
more obvious sources of racial differences in treatment within a hospital or provider 
group.  A potentially important, but not well understood, source of racial disparities 
cannot be solved by equal access to health care at the local level, or by universal health 
insurance for everyone. Instead, the disparities that occur when hospital or provider 
quality is worse in regions with a larger fraction of African-Americans can only be 
solved by addressing the problem of geographic disparities in health care.  As well, 
reducing geographic disparities will likely have a first-order impact on improving 
racial disparities in health care and health outcomes.  23
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Appendix A: Definitions used in the Dartmouth Atlas of Health Care 24 
Hospital Service Area: Hospital Service Areas (HSAs) represent local health care 
markets for community-based inpatient care. The definitions of HSAs used in the 1996 
edition of the Atlas were retained in the 1999 edition. HSAs were originally defined in 
three steps using 1993 provider files and 1992-93 utilization data. First, all acute care 
hospitals in the 50 states and the District of Columbia were identified from the 
American Hospital Association Annual Survey of Hospitals and the Medicare 
Provider of Services files and assigned to a location within a town or city. The list of 
towns or cities with at least one acute care hospital (N=3,953) defined the maximum 
number of possible HSAs. Second, all 1992 and 1993 acute care hospitalizations of the 
Medicare population were analyzed according to ZIP Code to determine the 
proportion of residents' hospital stays that occurred in each of the 3,953 candidate 
HSAs. ZIP Codes were initially assigned to the HSA where the greatest proportion 
(plurality) of residents were hospitalized. Approximately 500 of the candidate HSAs 
did not qualify as independent HSAs because the plurality of patients resident in 
those HSAs were hospitalized in other HSAs. The third step required visual 
examination of the ZIP Codes used to define each HSA. Maps of ZIP Code boundaries 
were made using files obtained from Geographic Data Technologies (GDT) and each 
HSA's component ZIP Codes were examined. In order to achieve contiguity of the 
component ZIP Codes for each HSA, "island" ZIP Codes were reassigned to the 
enclosing HSA, and/or HSAs were grouped into larger HSAs. This process resulted in 
the identification of 3,436 HSAs, ranging in total 1996 population from 604 (Turtle 
Lake, North Dakota) to 3,067,356 (Houston) in the 1999 edition of the Atlas. 
Intuitively, one may think of HSAs as representing the geographic level at which 
“front end” services such as diagnoses are received.  
Hospital Referral Region: Hospital service areas make clear the patterns of use of 
local hospitals. A significant proportion of care, however, is provided by referral 
hospitals that serve a larger region. Hospital referral regions were defined in the Atlas 
by documenting where patients were referred for major cardiovascular surgical 
procedures and for neurosurgery. Each hospital service area was examined to 
determine where most of its residents went for these services. The result was the 
aggregation of the 3,436 hospital service areas into 306 hospital referral regions. Each 
hospital referral region had at least one city where both major cardiovascular surgical 
procedures and neurosurgery were performed. Maps were used to make sure that the 
small number of "orphan" hospital service areas - those surrounded by hospital 
service areas allocated to a different hospital referral region - were reassigned, in 
almost all cases, to ensure geographic contiguity. Hospital referral regions were 
                                                 
24 We have duplicated the definitions used in CECS (1999a, 1999b). For further 
details on the construction methods see 
http://www.dartmouthatlas.org/99US/toc8.php. 32
   
pooled with neighbors if their populations were less than 120,000 or if less than 65% of 
their residents' hospitalizations occurred within the region. Hospital referral regions 
were named for the hospital service area containing the referral hospital or hospitals 
most often used by residents of the region. The regions sometimes cross state 
boundaries. Intuitively, one may think of HRRs as representing the geographic level 
at which “back end” services such as invasive surgery are received. 
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Table 1:  Cardiovascular Deaths Per 100,000 Population for Men: 
  Mississippi and Massachusetts 
  Black Mortality Rate  White Mortality Rate  Ratio: Black/White 
Both States Combined  900  668  1.35 
Mississippi 1028  835  1.23 
Massachusetts 580  616  0.94 
Notes:  Cardiovascular data from CDC (2001).  Black and white state population numbers (total, not by sex)
from Statistical Abstract (2001) and are for 1998. 34
   
Figure 1: Construction of the Evansville, Indiana Hospital 
Referral Region  
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Figure 2: Geographic Variation in Illness Adjusted Medicare Payments 
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Figure 3: Geographic Variation in PTCA Rates 
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Source: Dartmouth Atlas of Health Care. Each data point represents an observation for a 
Hospital Referral Region relative to the US average standardized for age-gender-race 
and illness.  38
   
Figure 5: Lorenz Curve Showing Distribution of Black and Nonblack AMI 
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Figure 6: Ninety-Day PTCA Rates per AMI Patient in the Medicare Population, 






















   
 
Figure 7: Percent of Appropriate AMI Patients Treated with Beta 
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% Beta Blocker = 74.9 - .32 x {% Black},  t-stat. = -2.3, R
2 = .08  41
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Omitting Quality or the correct measure of geography from the regression and comparing the 
racial difference in mortality (risk-adjusted or otherwise) will yield an estimate of ∆ = 
E[Mortality|Black]- E[Mortality|White]. However, if whites are more likely to be seen at high 
quality hospitals than blacks, ∆ is overstated. In the true regression, there is no effect of race 








Data cloud for Blacks 
Data cloud for Whites 
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Here, African Americans have worse outcomes even within the same hospitals. This correct 
race difference is β2 (the distance between the lines for Blacks and Whites at the same level of 
quality, or within the same geographical unit). Omitting Quality or the correct measure of 
geography from the regression and comparing the racial difference in mortality (risk-adjusted 
or otherwise) will yield an estimate of ∆ = E[Mortality|Black]- E[Mortality|White]. It can be 






Mortality  True Regression: 
E[Mortality|Quality] = β0+ β1Quality + β2 Black 
Geography or Hospital Quality44
   
Figure 9c: Geography and the Measurement of Racial Disparities 
 
 
Here, African Americans have worse outcomes even within the same hospitals and the race 
difference grows in worse hospitals. This correct race differential is β1  Quality + β2. 
Graphically, this is the height of the larger arrow. Omitting the Quality x Race interaction 
leads to severely understating the gap (the regression line will be weighted heavily by the 





Geography or Hospital Quality
Mortality  True Regression: 
E[Mortality|Quality] = β0+ β1Quality + β2Black 
     + β3(Black x Quality)
Estimated Regression (Biased): 
E[Mortality|Quality] = γ0+ γ1Quality + γ2Black 
γ2